Agilent 6230B Accurate-Mass Time-of-Flight Liquid Chromatography Mass Spectrometry System

Overview

The Agilent 6230B Accurate-Mass Time-of-Flight Liquid Chromatography Mass Spectrometry System is a high-performance quadrupole-time-of-flight (Q-TOF) platform engineered for untargeted and targeted screening, structural elucidation, and quantitative analysis across pharmaceutical, biopharmaceutical, environmental, and food safety applications. Unlike unit-mass resolution instruments, the 6230B employs orthogonal acceleration time-of-flight (oa-TOF) mass analysis—where ions are pulsed into a field-free flight tube and separated based on their time-of-flight proportional to the square root of their mass-to-charge ratio (m/z). This principle enables simultaneous acquisition of full-spectrum, high-resolution, accurate-mass data without sacrificing duty cycle or sensitivity. Coupled with a dual-stage quadrupole front end, the system supports both high-resolution MS and MS/MS acquisition modes—including all-ion fragmentation (AIF) and data-dependent acquisition (DDA)—delivering definitive elemental composition assignment and confident compound identification.

Key Features

• Accurate mass measurement with RMS error <1 ppm across a broad m/z range (50–3200), enabling robust elemental composition determination and reduced false-positive identification in complex matrices.
• Mass resolution exceeding 22,000 (FWHM at m/z 556), sufficient to resolve isobaric interferences (e.g., C₃H₇N₂⁺ vs. C₂H₃N₃O⁺) in biological extracts and formulation impurities.
• High-speed spectral acquisition up to 30 Hz, fully synchronized with ultra-high-performance liquid chromatography (UHPLC) gradients—preserving peak fidelity and signal-to-noise ratio even for narrow (<3 s) chromatographic peaks.
• Agilent Jet Stream electrospray ionization (ESI) source delivers enhanced desolvation efficiency and ion transmission, achieving sub-picomolar on-column sensitivity for small molecules and stable signal response for peptides and intact proteins.
• Full-spectrum MS/MS capability via all-ion fragmentation (AIF), where precursor ions across the entire detected m/z range are fragmented in parallel—enabling retrospective analysis without pre-defined inclusion lists.
• Integrated mass calibration using dual internal reference ions ensures long-term mass stability over multi-hour acquisitions, critical for GLP-compliant workflows and regulatory submissions.

Sample Compatibility & Compliance

The 6230B accommodates diverse sample types—including polar and non-polar small molecules, peptides, oligonucleotides, glycoconjugates, and intact monoclonal antibodies—across reversed-phase, HILIC, ion-exchange, and SEC chromatographic modalities. Its hardware architecture and firmware comply with ISO/IEC 17025:2017 requirements for testing laboratories, and its software stack supports audit trails, electronic signatures, and instrument qualification documentation aligned with FDA 21 CFR Part 11 and EU Annex 11. The system is routinely validated per ICH Q2(R2) guidelines for method suitability in impurity profiling, degradation product identification, and peptide mapping studies.

Software & Data Management

Controlled by Agilent MassHunter Workstation Software (version B.08.00 or later), the 6230B provides a unified environment for instrument control, real-time data acquisition, post-run processing, and reporting. Key modules include:

• Find by Formula: Automatically generates candidate molecular formulas from accurate mass, isotope pattern fit, and user-defined element constraints (e.g., C, H, N, O, S, Cl, Br).
• Molecular Feature Extraction (MFE): Detects and aligns chromatographic features across sample sets, supporting untargeted metabolomics and comparative bioanalysis.
• Personal Compound Database and Library (PCDL): Includes curated libraries for toxicology (2,500+ compounds), veterinary drug residues (600+ compounds), and environmental contaminants—each with retention time, MS/MS spectra, and fragmentation pathways.
• Data export formats include mzML (PSI standard), .d directories, and CSV-compatible reports—ensuring interoperability with third-party platforms such as XCMS, MZmine, and commercial LIMS systems.

Applications

The 6230B serves as a primary analytical engine in regulated and discovery environments. Typical use cases include: structural characterization of unknown degradants in stability-indicating assays; identification of post-translational modifications (PTMs) in recombinant therapeutic proteins; confirmation of pesticide residues in food matrices per SANTE/2023/2023 guidance; differentiation of positional isomers in synthetic chemistry intermediates; and high-confidence biomarker discovery in plasma or urine via differential feature analysis. Its ability to acquire both MS and MS/MS data in a single run supports hybrid workflows—such as quantitative MRM-triggered HR-MS/MS—without method re-injection.

FAQ

Is the 6230B compliant with FDA 21 CFR Part 11 for electronic records and signatures?

Yes—the MassHunter software includes configurable audit trail logging, role-based access control, and electronic signature enforcement per Part 11 Annex A requirements.
Can the system perform quantitative analysis at low ng/mL levels?

Yes—when coupled with Agilent 1290 Infinity II UHPLC and optimized sample preparation, the 6230B achieves LOQs of 0.1–1 ng/mL for small-molecule analytes in plasma using external calibration and isotopically labeled internal standards.
Does it support scheduled or unscheduled maintenance alerts?

Yes—MassHunter’s Instrument Status Monitor provides real-time diagnostics, predictive alerts for source contamination or vacuum degradation, and automated log generation for preventive maintenance tracking.
What chromatographic interfaces are supported?

Standard configurations include ESI and APCI sources; optional nano-ESI, MALDI, and direct infusion modules are available via Agilent’s modular interface architecture.
How is mass calibration maintained during extended runs?

The system performs automatic lock-mass correction using dual reference ions (e.g., purine and HP-0921) injected continuously at 1% flow split, ensuring mass stability within ±0.2 ppm over 48-hour acquisitions.